The Clinical and Regulatory Affairs team at Alcyone Therapeutics plays a critical role in overseeing the development and implementation of clinical trials for their innovative CNS therapies. This team ensures compliance with regulatory requirements, facilitates communication with health authorities, and provides scientific guidance throughout the clinical development process. By integrating clinical insights and regulatory expertise, they help drive the advancement of Alcyone’s gene therapy programs targeting severe neurological conditions.
Dave Arnold
Scientific Advisor
Isabelle Aubert
Scientific Advisor
Jeffrey L. Neul
Scientific Advisor
Kathrin Meyer
Chief Scientific Advisor
Laura Ferraiuolo
Scientific Advisor
Maurizio Pellechia
Scientific Advisor
Nicolas Wein
Core Scientific Advisor
Roxana O Carare
Scientific Advisor
Sanchita Bhatnagar
Scientific Advisor
Timothy Benke
Scientific Advisor
View all